Ingelheim, Germany and Ann Arbor, MI, USA, November 12, 2024 – Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative (MTM Vision) today jointly announce the start of a long-term ...
Kikuchi–Fujimoto disease (KFD), histiocytic necrotising lymphadenitis, is a benign and self-limiting disease characterised ...
Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...
No. 49 / 2024Zealand Pharma Announces Financial Results for the First Nine Months of 2024Continued strong progress across ...
Substantial enrollment progress in Phase 1b trial of SZN-043 in severe alcohol-associated hepatitis patients with proof-of-concept data expected ...
Danish biotech Gubra announces that Germany’s Boehringer Ingelheim has decided to discontinue the development of the long-acting neuropeptide Y receptor type 2 (NPY2R) agonist BI 1820237 in obesity.
Privately-held German drugmaker Boehringer Ingelheim and researchers from the Stanley Center for Psychiatric Research at the ...
The National Turkey Federation supports import permit to improve treatment of the contagious respiratory disease.
Loya opened up about his unforgettable experience as a Commercial Quality Intern at Boehringer Ingelheim. “During my 3-months tenure, I worked closely with the Commercial Quality team assisting ...
Detailed price information for Argo Living Soils Corp (ARGO-CN) from The Globe and Mail including charting and trades.
The new Mercedes-Benz eEconic is a first of its kind all-electric tanker truck helping to reduce emissions at Airbus’ Donauwörth facility by pumping sustainable aviation fuel (SAF) into new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback